Top 3D Printing companies in Australia by Price to Sales Ratio (P/S)
Australia
# |
Name |
Price to Sales Ratio (P/S) |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
397.70 |
Feb. 5, 2025 | USD 1.90 | -4.74% |
|
Australia |
|
| 2 |
174.97 |
Feb. 5, 2025 | USD 181.62 | 2.38% |
|
Australia |
|
| 3 |
99.76 |
Feb. 5, 2025 | USD 2.46 | 10.79% |
|
Australia |
|
| 4 |
81.65 |
Feb. 5, 2025 | USD 6.16 | 2.82% |
|
Australia |
|
| 5 |
18.11 |
Feb. 5, 2025 | USD 18.33 | -0.84% |
|
Australia |
|
| 6 |
12.31 |
Feb. 5, 2025 | USD 1.23 | -0.40% |
|
Australia |
|
| 7 |
8.66 |
Feb. 5, 2025 | USD 1.45 | -3.95% |
|
Australia |
|
| 8 |
8.58 |
Feb. 5, 2025 | USD 195.76 | 0.28% |
|
Australia |
|
| 9 |
5.67 |
Feb. 5, 2025 | USD 5.16 | 1.74% |
|
Australia |
|
| 10 |
5.27 |
Feb. 5, 2025 | USD 10.31 | 2.62% |
|
Australia |
|
| 11 |
2.26 |
Feb. 5, 2025 | USD 1.90 | 0.29% |
|
Australia |
|
| 12 |
1.67 |
Feb. 5, 2025 | USD 0.74 | 0.62% |
|
Australia |
Frequently Asked Questions
-
Which 3D Printing company in Australia has the highest Price to Sales Ratio (P/S) ?
The 3D Printing company in Australia with the highest Price to Sales Ratio (P/S) is Mesoblast Limited (ASX: MSB.AX) at 397.70.
-
Which 3D Printing company in Australia has the lowest Price to Sales Ratio (P/S) ?
The 3D Printing company in Australia with the lowest Price to Sales Ratio (P/S) is Monash IVF Group Limited (ASX: MVF.AX) at 1.67.
-
What are the top 10 3D Printing companies in Australia by Price to Sales Ratio (P/S) ?
The top 10 3D Printing companies in Australia by Price to Sales Ratio (P/S) are Mesoblast Limited, Pro Medicus Limited, Clarity Pharmaceuticals Ltd, Anteris Technologies Ltd, Telix Pharmaceuticals Limited, PolyNovo Limited, Cyclopharm Limited, Cochlear Limited, PWR Holdings Limited and Codan Limited.
-
What are the bottom 10 3D Printing companies in Australia by Price to Sales Ratio (P/S) ?
The bottom 10 3D Printing companies in Australia by Price to Sales Ratio (P/S) are Monash IVF Group Limited, Integral Diagnostics Limited, Codan Limited, PWR Holdings Limited, Cochlear Limited, Cyclopharm Limited, PolyNovo Limited, Telix Pharmaceuticals Limited, Anteris Technologies Ltd and Clarity Pharmaceuticals Ltd.
